Monimus Capital Management’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Sell
41,012
-773
-2% -$274K 3.82% 5
2026
Q1
$13.4M Buy
41,785
+22,966
+122% +$6.84M 3.72% 5
2025
Q4
$4.87M Sell
18,819
-1,682
-8% -$383K 3.21% 9
2025
Q3
$4.65M Sell
20,501
-5,789
-22% -$1.19M 2.87% 10
2025
Q2
$5.49M Buy
26,290
+2,245
+9% +$432K 3.99% 6
2025
Q1
$4.68M Sell
24,045
-2,676
-10% -$553K 3.97% 7
2024
Q4
$6.03M Buy
+26,721
New +$5.97M 5.68% 3

Other funds holding MSGS

Monimus Capital Management's MSGS Position: Q2 2026 in Review

Monimus Capital Management reduced its Madison Square Garden (MSGS) stake by 1.8% in Q2 2026, selling an estimated $274K and leaving 41,012 shares worth $16.5M. The position accounts for 3.82% of the portfolio, ranked #5.

Monimus Capital Management first reported a position in MSGS in Q4 2024 and has held it in 7 quarters since. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Monimus Capital Management held 41,012 shares of Madison Square Garden worth $16.5M as of Q2 2026.
  • Monimus Capital Management sold 773 Madison Square Garden shares in Q2 2026, an estimated $274K.
  • Madison Square Garden made up 3.82% of Monimus Capital Management's portfolio in Q2 2026, its #5 holding.
  • Monimus Capital Management first reported a position in Madison Square Garden in Q4 2024 and has held it in 7 quarters since.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Monimus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.